Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2041 studies found for:    Peripheral Neuropathy
Show Display Options
Rank Status Study
21 Completed
Has Results
A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy
Condition: Diabetic Peripheral Neuropathy
Interventions: Drug: Tapentadol extended release (ER);   Drug: Placebo
22 Completed Effects of Reiki, Yoga, Meditation, on the Physical and Psychological Symptoms of Chemotherapy-Induced Peripheral Neuropathy
Condition: Peripheral Neuropathy
Interventions: Behavioral: Yoga Intervention;   Behavioral: Meditation Intervention;   Behavioral: Reiki;   Other: Holistic Education
23 Terminated Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy
Condition: Painful Diabetic Peripheral Neuropathy (PDPN)
Interventions: Drug: ASP3662;   Drug: pregabalin;   Drug: ASP3662 placebo;   Drug: pregabalin placebo
24 Recruiting The Effectiveness and Cost-effectiveness of Acupuncture in Managing Chemotherapy-induced Peripheral Neuropathy
Condition: Chemotherapy-induced Peripheral Neuropathy
Interventions: Procedure: Acupuncture;   Procedure: Standard care
25 Completed Motor Learning in Gait in Subjects With Diabetic Peripheral Neuropathy
Conditions: Diabetes;   Peripheral Neuropathy
Interventions: Behavioral: Gait Training with Feedback;   Behavioral: Gait Training with no feedback
26 Terminated Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
Conditions: Chemotherapeutic Agent Toxicity;   Multiple Myeloma;   Peripheral Neuropathy
Interventions: Drug: glutamine;   Other: quality-of-life assessment;   Other: placebo
27 Recruiting Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy
Condition: Pain
Interventions: Procedure: Neurofeedback Training;   Procedure: Electroencephalogram;   Behavioral: Pain Scale;   Behavioral: Questionnaires
28 Completed
Has Results
Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Conditions: Peripheral Neuropathy;   Neuropathic Pain
Interventions: Drug: ADL5859;   Drug: Duloxetine;   Drug: Placebo
29 Completed Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Neurotoxicity;   Pain;   Peripheral Neuropathy;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: duloxetine hydrochloride;   Other: placebo
30 Recruiting A Post Market Cohort With the Spinal Modulation Neurostimulator System in Peripheral Neuropathy
Condition: Peripheral Neuropathy
Intervention: Device: Implantation with the commercially available Axium neurostimulator
31 Terminated
Has Results
A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy
Condition: Peripheral Neuropathy, Chemotherapy-induced
Interventions: Drug: PROCRIT 40,000 IU QW;   Drug: Placebo
32 Completed Acupuncture/Moxibustion for Peripheral Neuropathy in HIV
Conditions: Peripheral Neuropathies;   HIV Infections
Intervention: Procedure: Acupuncture/Moxibustion
33 Terminated
Has Results
Near Infrared Light for the Treatment of Painful Peripheral Neuropathy
Condition: Peripheral Neuropathy
Interventions: Device: MIRE;   Device: Sham Device
34 Completed The Effect of Pregabalin on Pain Related to Walking in Patients With Diabetic Peripheral Neuropathy
Conditions: Diabetic Peripheral Neuropathy;   Nerve Pain
Interventions: Drug: Pregabalin;   Drug: Placebo
35 Unknown  Can Ultrasound Predict Nerve Injury Following Posterior Tibial Nerve Block in Patients With Peripheral Neuropathy?
Condition: Diabetic Neuropathy
Intervention: Procedure: Nerve conduction study and Ultrasound of the PTN
36 Completed Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy
Condition: Diabetic Peripheral Neuropathy
Interventions: Drug: Gabapentin Extended Release tablets;   Drug: Placebo
37 Active, not recruiting Effect Of Mesenchymal Stem Cells Transfusion on the Diabetic Peripheral Neuropathy Patients .
Condition: Diabetic Peripheral Neuropathy
Intervention: Genetic: mesenchymal stem cells
38 Withdrawn Oral Thiamine for the Treatment of Painful Diabetic Peripheral Neuropathy
Conditions: Peripheral Neuropathy;   Diabetes Mellitus;   Diabetes Complications
Intervention: Drug: Thiamine
39 Completed Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy
Condition: Diabetic Peripheral Neuropathy
Interventions: Drug: CNV2197944;   Drug: Placebo
40 Completed
Has Results
Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer
Conditions: Neurotoxicity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Dietary Supplement: vitamin E;   Other: placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.